Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5076 - 5100 of 10619 in total
Experimental
Semapimod has been used in trials studying the treatment of Crohn Disease.
Investigational
Matched Description: … Semapimod has been used in trials studying the treatment of Crohn Disease. …
Solnatide has been used in trials studying the treatment of Acute Lung Injury.
Investigational
Matched Description: … Solnatide has been used in trials studying the treatment of Acute Lung Injury. …
Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.
Investigational
Matched Description: … Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer …
Silatecan has been used in trials studying the treatment of GBM, Tumors, Gliosarcoma, Solid Malignancies, and Glioblastoma Multiforme, among others.
Investigational
Matched Description: … Silatecan has been used in trials studying the treatment of GBM, Tumors, Gliosarcoma, Solid Malignancies …
Saccharin has been investigated for the treatment of Hypertension and Hyperglycemia.
Investigational
Matched Description: … Saccharin has been investigated for the treatment of Hypertension and Hyperglycemia. …
Sch 900271 has been used in trials studying the treatment of Mixed Hyperlipidemia and Primary Hypercholesterolemia.
Investigational
Matched Description: … Sch 900271 has been used in trials studying the treatment of Mixed Hyperlipidemia and Primary Hypercholesterolemia …
Sonolisib has been used in trials studying the treatment of Glioblastoma, Prostate Cancer, Advanced Solid Tumors, Advanced BRAF-mutant Cancers, and Non Small Cell Lung Cancer (NSCLC), among others.
Investigational
Matched Description: … Sonolisib has been used in trials studying the treatment of Glioblastoma, Prostate Cancer, Advanced Solid …
Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.
Investigational
Matched Description: … Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung. …
Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms.
Experimental
Matched Description: … Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms. …
Experimental
Sucralose is an artificial sweetener used as a sugar substitute.
Experimental
Sulopenem is under investigation in clinical trial NCT03357614 (Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults).
Investigational
Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced Malignant Solid Tumors).
Investigational
Spiperone is a dopamine antagonist that binds dopamine and serotonin receptors.
Investigational
Sigvotatug vedotin (SGN-B6A) is a humanized immunoglobulin G1 anti-integrin beta-6 monoclonal antibody conjugated to monomethyl auristatin E.
Investigational
SLN500 is a synthetic double-strand small interfering ribonucleic acid (siRNA) oligonucleotide drug directed against C3 messenger RNA
Investigational
SLN124 is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.
Investigational
D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.g12c Mutation).
Investigational
Matched Description: … D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination …
Supinoxin is under investigation in clinical trial NCT02003092 (RX-5902 Treatment of Subjects With Triple Negative Breast Cancer).
Investigational
Matched Description: … Supinoxin is under investigation in clinical trial NCT02003092 (RX-5902 Treatment of Subjects With Triple …
SLV319 belongs to a novel class of agents called CB1 antagonists, which work by blocking the cannabinoid type 1 (CB1) receptor. It is developed for the treatment of obesity and other metabolic disorders.
Investigational
Matched Description: … It is developed for the treatment of obesity and other metabolic disorders. ... SLV319 belongs to a novel class of agents called CB1 antagonists, which work by blocking the cannabinoid …
Investigational
Sparteine is a plant alkaloid derived from Cytisus scoparius and Lupinus mutabilis which may chelate calcium and magnesium. It is a sodium channel blocker, so it falls in the category of class 1a antiarrhythmic agents. Sparteine is not currently FDA-approved for human use, and its salt, sparteine sulfate, is one...
Experimental
Withdrawn
Matched Description: … It is a sodium channel blocker, so it falls in the category of class 1a antiarrhythmic agents. ... Sparteine is not currently FDA-approved for human use, and its salt, sparteine sulfate, is one of the ... products that have been withdrawn or removed from the market for reasons of safety or effectiveness. …
Displaying drugs 5076 - 5100 of 10619 in total